International Biotechnology (LON:IBT – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 953.56 and traded as high as GBX 1,090. International Biotechnology shares last traded at GBX 1,083.50, with a volume of 59,399 shares trading hands.
International Biotechnology Stock Performance
The company has a current ratio of 0.11, a quick ratio of 0.32 and a debt-to-equity ratio of 9.43. The stock has a market capitalization of £344.86 million, a price-to-earnings ratio of 4.48 and a beta of 0.52. The firm’s fifty day moving average price is GBX 984.75 and its 200 day moving average price is GBX 953.56.
International Biotechnology (LON:IBT – Get Free Report) last announced its earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. The firm had revenue of GBX 24 million for the quarter. Analysts forecast that International Biotechnology will post 0.9435943 EPS for the current fiscal year.
About International Biotechnology
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Read More
- Five stocks we like better than International Biotechnology
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
